We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Lantronix
LTRX
$223M
| $400K | ﹤0.01% |
92,704
+67,063
| +262% | +$316K |
|
|
CBD
2427
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $399K | ﹤0.01% |
128,810
-157,481
| -55% | -$572K |
|
2428
Energy Recovery
ERII
$420M
| $399K | ﹤0.01% |
19,482
-27,318
| -58% | -$598K |
|
2429
Identive
INVE
$61M
| $398K | ﹤0.01% |
55,018
+42,656
| +345% | +$413K |
|
2430
IES Holdings
IESC
$9.89B
| $397K | ﹤0.01% |
+11,155
| New | +$362K |
|
2431
nVent Electric
NVT
$21.6B
| $396K | ﹤0.01% |
+10,300
| New | +$380K |
|
|
ADVWW
2432
CALL
DELISTED
Advantage Solutions Warrant
ADVWW
| $394K | ﹤0.01% |
189,295
-1,530
| -0.8% | -$282 |
|
2433
Cummins
CMI
$83.6B
| $394K | ﹤0.01% |
1,625
-32,750
| -95% | -$7.79M |
|
2434
Chemours
CC
$2.48B
| $392K | ﹤0.01% |
12,809
-62,024
| -83% | -$1.86M |
|
2435
Cricut
CRCT
$1.01B
| $392K | ﹤0.01% |
42,308
-101,394
| -71% | -$937K |
|
2436
Roivant Sciences
ROIV
$23.6B
| $391K | ﹤0.01% |
48,981
-94,432
| -66% | -$525K |
|
2437
American Water Works
AWK
$27B
| $391K | ﹤0.01% |
2,566
-18,734
| -88% | -$2.7M |
|
2438
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.14B
| $390K | ﹤0.01% |
+19,000
| New | +$382K |
|
|
WEL.WS
2439
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
| $390K | ﹤0.01% |
37,499
| – | – |
|
2440
SIGA Technologies
SIGA
$240M
| $387K | ﹤0.01% |
52,612
-17,661
| -25% | -$155K |
|
2441
JPMorgan Equity Premium Income ETF
JEPI
$45.5B
| $387K | ﹤0.01% |
+7,100
| New | +$386K |
|
2442
Iridium Communications
IRDM
$4.7B
| $387K | ﹤0.01% |
+7,524
| New | +$378K |
|
2443
OneWater Marine
ONEW
$211M
| $387K | ﹤0.01% |
13,520
+4,293
| +47% | +$134K |
|
2444
Distribution Solutions Group
DSGR
$1.6B
| $386K | ﹤0.01% |
20,966
-32,142
| -61% | -$540K |
|
|
APMIW
2445
CALL
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
| $386K | ﹤0.01% |
39,015
| – | – |
|
2446
Veritone
VERI
$92.9M
| $386K | ﹤0.01% |
72,758
+40,981
| +129% | +$263K |
|
2447
Century Communities
CCS
$1.98B
| $385K | ﹤0.01% |
+7,700
| New | +$364K |
|
2448
Preferred Bank
PFBC
$1.24B
| $384K | ﹤0.01% |
+5,150
| New | +$375K |
|
|
PRO
2449
DELISTED
PROS Holdings
PRO
| $381K | ﹤0.01% |
15,700
-6,396
| -29% | -$157K |
|
|
ARKOW
2450
CALL
DELISTED
ARKO Corp Warrant
ARKOW
| $381K | ﹤0.01% |
+43,959
| New | +$82.9K |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.